HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 238 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Why Your Virtual Event Flopped — and the 7-Step Framework to Make the Next One Your Best Yet Strategy Hilton’s Early-Career Program Has a Lower Acceptance Rate Than the Ivy League Strategy The Road Less Traveled — The 3 Unconventional Paths I Took to Build a Successful Startup Strategy How Oatly Became a Creative Force, by Breaking All of Marketing’s Rules Must Read Known Systems AI spins out of Identity Digital to make AI agents accountable to their owners Tech Training data provider Snorkel AI raises $350M at $3.5B valuation Tech Why Your Virtual Event Flopped — and the 7-Step Framework to Make the Next One Your Best Yet Strategy Hilton’s Early-Career Program Has a Lower Acceptance Rate Than the Ivy League Strategy Cisco Talos finds malware that puts its next move to a four-model vote Tech